Adelbelimab Combination Chemotherapy in Neoadjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Nab paclitaxel; Drug: Carboplatin; Drug: adelbelimumab Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Skin Cancer | Squamous Cell Carcinoma